Yale Cancer Center

Futó vizsgálatok

• Toboroz

  Bexmarilimab + Azacitidine Versus Placebo + Azacitidine in Participants With Treatment-naïve Higher-risk Myelodysplastic Syndromes

  NCT07672769· 2. fázis· Faron Pharmaceuticals Ltd· Forrás

• Toboroz

  A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer

  NCT07701941· 1/2. fázis· Daiichi Sankyo· Forrás

• Toboroz

  A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)

  NCT07421167· 2. fázis· Novartis Pharmaceuticals· Forrás

• Toboroz

  SI-B036-ST-101 in Advanced/Metastatic Solid Tumors

  NCT07857616· 1. fázis· SystImmune Inc.· Forrás

• Toboroz

  A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

  NCT07101328· 1. fázis· Eli Lilly and Company· Forrás

• Toboroz

  A Phase 1 Study of IM-1617 in Participants With Advanced Cancer

  NCT07578571· 1. fázis· Immunome, Inc.· Forrás

• Toboroz

  Study of INCA036978 in Participants With Myeloproliferative Neoplasms

  NCT07441694· 1. fázis· Incyte Corporation· Forrás

• Toboroz

  Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

  NCT07326566· 2. fázis· Black Diamond Therapeutics, Inc.· Forrás

• Toboroz

  A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or Metastatic Prostate Cancer

  NCT07567846· 1/2. fázis· Genentech, Inc.· Forrás

• Toboroz

  A Study of GEN1106 in Participants With Solid Tumors

  NCT07416123· 1. fázis· Genmab· Forrás

• Toboroz

  A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

  NCT07503808· 1. fázis· IDEAYA Biosciences· Forrás

• Toboroz

  A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

  NCT07258511· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

  NCT07349537· 1. fázis· Revolution Medicines, Inc.· Forrás

• Toboroz

  A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors

  NCT07361562· 1. fázis· Cogent Biosciences, Inc.· Forrás

• Meghívásos bevonás

  Liquid Biopsy in Glioblastoma Treated With Chemoradiation and an Oxygen Therapeutic

  NCT07417774· NuvOx LLC· Forrás

• Toboroz

  A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

  NCT07276399· 3. fázis· Janssen Research & Development, LLC· Forrás

• Meghívásos bevonás

  A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4

  NCT07218003· 1. fázis· Rondo Therapeutics· Forrás

• Toboroz

  M0324 as Monotherapy and in Combination With Pembrolizumab or Chemotherapy in Participants With Selected Advanced Solid Tumors

  NCT07166601· 1. fázis· EMD Serono Research & Development Institute, Inc.· Forrás

• Toboroz

  A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors

  NCT07169734· 1/2. fázis· Alentis Therapeutics AG· Forrás

• Toboroz

  Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NSCLC

  NCT07098988· 2. fázis· CatalYm GmbH· Forrás

• Fut, nem toboroz

  Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects With Solid Tumors

  NCT07021066· 1. fázis· SystImmune Inc.· Forrás

• Toboroz

  Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis

  NCT06950385· 3. fázis· Rapamycin Holdings Inc.· Forrás

• Fut, nem toboroz

  An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

  NCT06991556· 2. fázis· Novartis Pharmaceuticals· Forrás

• Toboroz

  Efficacy and Safety Evaluation of VS-101 in Combination With Chemoradiotherapy in Patients With Head and Neck Cancer

  NCT06959082· 2. fázis· VSPharmTech Co.,Ltd.· Forrás

• Toboroz

  Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors

  NCT07080242· 1. fázis· SystImmune Inc.· Forrás

• Toboroz

  A Study of PHST001 in Advanced Solid Tumors

  NCT06840886· 1. fázis· Pheast Therapeutics· Forrás

• Toboroz

  A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

  NCT07029399· 1. fázis· NiKang Therapeutics, Inc.· Forrás

• Toboroz

  Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

  NCT06731478· 3. fázis· Daiichi Sankyo· Forrás

• Toboroz

  SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma

  NCT06743126· 3. fázis· Immatics US, Inc.· Forrás

• Toboroz

  First in Human Study of TUB-030 in Patients With Advanced Solid Tumors

  NCT06657222· 1/2. fázis· Gilead Sciences· Forrás

• Toboroz

  Revumenib in Combination With 7+3 + Midostaurin in AML

  NCT06313437· 1. fázis· Richard Stone, MD· Forrás

• Toboroz

  A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer

  NCT06638307· 1. fázis· Stemline Therapeutics, Inc.· Forrás

• Fut, nem toboroz

  A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors

  NCT06607185· 1. fázis· Eli Lilly and Company· Forrás

• Toboroz

  QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer

  NCT06551116· Abramson Cancer Center at Penn Medicine· Forrás

• Fut, nem toboroz

  A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Participants With Previously Treated KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer

  NCT06497556· 3. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

  NCT06246916· 3. fázis· Regeneron Pharmaceuticals· Forrás

• Toboroz

  Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

  NCT06393374· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

  NCT06343402· 1. fázis· TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)· Forrás

• Fut, nem toboroz

  A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors

  NCT05973487· 1. fázis· TScan Therapeutics, Inc.· Forrás

• Toboroz

  A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer

  NCT06385080· 1/2. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  The SUGAR Study; SBRT and Relugolix) for Prostate Cancer

  NCT06111781· 2. fázis· Yale University· Forrás

• Toboroz

  A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

  NCT06312176· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

  NCT06172478· 2. fázis· Daiichi Sankyo· Forrás

• Toboroz

  A Study of AK117 in Combination With Azacitidine in Patients With Myelodysplastic Syndromes

  NCT06196203· 2. fázis· Akeso· Forrás

• Toboroz

  A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma

  NCT06153251· 1. fázis· Juno Therapeutics, Inc., a Bristol-Myers Squibb Company· Forrás

• Toboroz

  A Study of ZL-1310 in Subjects With Small Cell Lung Cancer

  NCT06179069· 1. fázis· Zai Lab (Shanghai) Co., Ltd.· Forrás

• Toboroz

  Sipuleucel-T Combined With Bipolar Androgen Therapy in Men With mCRPC

  NCT06100705· 2. fázis· Yale University· Forrás

• Fut, nem toboroz

  A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2

  NCT06003231· 2. fázis· Seagen, a wholly owned subsidiary of Pfizer· Forrás

• Toboroz

  A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma

  NCT06084936· 3. fázis· Hoffmann-La Roche· Forrás

• Fut, nem toboroz

  A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDAC

  NCT05968326· 2. fázis· Genentech, Inc.· Forrás

Showing 50 of 93.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Tüdőrák19 toboroz
• Fej-nyaki daganatok9 toboroz
• Tripla negatív emlőrák9 toboroz
• Prosztatarák8 toboroz
• Vastagbélrák7 toboroz
• Áttétes emlőrák6 toboroz
• Gyomor- és nyelőcsőrák5 toboroz
• Méhtestrák5 toboroz
• Melanóma5 toboroz
• Petefészekrák5 toboroz
• Hasnyálmirigyrák4 toboroz
• Hólyagrák4 toboroz
• Follikuláris limfóma3 toboroz
• Köpenysejtes limfóma3 toboroz
• Máj- és epeúti rák3 toboroz
• Glioblasztóma2 toboroz
• Gyermekkori daganatok2 toboroz
• Méhnyakrák2 toboroz
• Mielodiszplasztikus szindróma (MDS)2 toboroz
• Mielóma multiplex2 toboroz
• Szarkóma2 toboroz
• Akut mieloid leukémia (AML)1 toboroz
• Diffúz nagy B-sejtes limfóma (DLBCL)1 toboroz
• Immune thrombocytopenia (ITP)1 toboroz
• Krónikus limfoid leukémia (CLL)1 toboroz
• Mieloproliferatív neopláziák1 toboroz
• Neuroendokrin daganatok1 toboroz
• Pajzsmirigyrák1 toboroz
• Vesedaganat1 toboroz

Lezárt vizsgálatok

• Leállították

  Evaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors

  NCT06714617· 1. fázis· SystImmune Inc.· Forrás

• Toboroz

  A Study to Investigate ALE.P02 as a Monotherapy or in Combination With Pembrolizumab in Adult Patients With Selected CLDN1+ Solid Tumors

  NCT06747585· 1/2. fázis· Alentis Therapeutics AG· Forrás

• Toboroz

  A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors

  NCT06326411· 1. fázis· Nested Therapeutics, Inc· Forrás

• Lezárult

  Brightline-4: A Study to Test How Well Brigimadlin is Tolerated by People With a Type of Cancer Called Dedifferentiated Liposarcoma

  NCT06058793· 3. fázis· Boehringer Ingelheim· Forrás

• Visszavonták

  Oral Azacitidine (CC-486) Epigenetic Priming and Maintenance for Adult Acute Myeloid Leukemia (AML) Patients

  NCT06180863· 2. fázis· Yale University· Forrás

• Toboroz

  Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring

  NCT05974150· Carevive Systems, Inc.· Forrás

• Toboroz

  Exercise in Metastatic Breast Cancer: EMBody

  NCT05468034· Indiana University· Forrás

• Lezárult

  A First-in-human Study of PRTH-101 Monotherapy +/- Pembrolizumab in Subjects With Advanced Malignancies

  NCT05753722· 1. fázis· Incendia Therapeutics· Forrás

• Lezárult

  Study Of ATRN-119 In Patients With Advanced Solid Tumors

  NCT04905914· 1/2. fázis· Aprea Therapeutics· Forrás

• Leállították

  A Study of Botensilimab (AGEN1181) for the Treatment of Advanced Melanoma

  NCT05529316· 2. fázis· Agenus Inc.· Forrás

• Toboroz

  A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

  NCT05548296· 2. fázis· Acrivon Therapeutics· Forrás

• Leállították

  Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma or Other Primary Central Nervous System Tumors Harboring Activating FGFR1-3 Alterations

  NCT05267106· 2. fázis· Incyte Corporation· Forrás

• Leállították

  A Study of SGN-ALPV in Advanced Solid Tumors

  NCT05229900· 1. fázis· Seagen Inc.· Forrás

• Lezárult

  A Study of hSTC810 With Advanced/Metastatic Solid Tumors (STCUBE-001)

  NCT05231746· 1. fázis· STCube, Inc.· Forrás

• Leállították

  Study of Posoleucel (ALVR105,Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant

  NCT05305040· 2/3. fázis· AlloVir· Forrás

• Leállították

  Phase 1 Study of Shattuck Labs (SL)-172154 in Subjects With MDS or AML

  NCT05275439· 1. fázis· Shattuck Labs, Inc.· Forrás

• Lezárult

  Pepinemab in Combination With Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

  NCT04815720· 1/2. fázis· Vaccinex Inc.· Forrás

• Leállították

  A Safety and Tolerability Study of NC762 in Subjects With Advanced or Metastatic Solid Tumors

  NCT04875806· 1/2. fázis· NextCure, Inc.· Forrás

• Lezárult

  An Open Label Study Evaluating the Efficacy and Safety of Etrumadenant (AB928) Based Treatment Combinations in Participants With Metastatic Colorectal Cancer.

  NCT04660812· 1/2. fázis· Arcus Biosciences, Inc.· Forrás

• Lezárult

  Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors

  NCT04902872· 1/2. fázis· Cybrexa Therapeutics· Forrás

• Leállították

  Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors

  NCT04931823· 1. fázis· Conjupro Biotherapeutics, Inc.· Forrás

• Leállították

  Efficacy of MT-401 in Patients With AML Following Stem Cell Transplant

  NCT04511130· 2. fázis· Marker Therapeutics, Inc.· Forrás

• Lezárult

  A Study of APX005M in Combination With Nivolumab and Ipilimumab in Treatment Naïve Patients With Advanced Melanoma or Renal Cell Carcinoma (RCC)

  NCT04495257· 1. fázis· Yale University· Forrás

• Leállították

  A Study of Xevinapant (Debio 1143) in Combination With Platinum-Based Chemotherapy and Standard Fractionation Intensity-Modulated Radiotherapy in Participants With Locally Advanced Squamous Cell Carcinoma of the Head and Neck, Suitable for Definitive Chemoradiotherapy (TrilynX)

  NCT04459715· 3. fázis· EMD Serono Research & Development Institute, Inc.· Forrás

• Lezárult

  Study of Early Relapsed, Lenalidomide-refractory Subjects Eligible for Carfilzomib Triplet

  NCT04191616· 2. fázis· Amgen· Forrás

• Leállították

  A Safety Study of SEA-TGT (SGN-TGT) in Advanced Cancer

  NCT04254107· 1. fázis· Seagen Inc.· Forrás

• Lezárult

  A Study to Find a Safe and Effective Dose of BI 905711 in Patients With Advanced Gastrointestinal Cancer

  NCT04137289· 1. fázis· Boehringer Ingelheim· Forrás

• Lezárult

  A Study of Tiragolumab in Combination With Atezolizumab Compared With Placebo in Combination With Atezolizumab in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1-Selected Non-Small Cell Lung Cancer

  NCT04294810· 3. fázis· Hoffmann-La Roche· Forrás

• Leállították

  Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors

  NCT04234113· 1. fázis· SOTIO Biotech AG· Forrás

• Lezárult

  Phase 3 Trial of Elacestrant Versus Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer

  NCT03778931· 3. fázis· Stemline Therapeutics, Inc.· Forrás

• Lezárult

  Safety and Efficacy Study of Pembrolizumab (MK-3475) Combined With Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Advance Melanoma (MK-7902-003/E7080-G000-312/LEAP-003)

  NCT03820986· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  Dose Escalation Study of mRNA-2752 for Intratumoral Injection to Participants in Advanced Malignancies

  NCT03739931· 1. fázis· ModernaTX, Inc.· Forrás

• Lezárult

  Dose Escalation and Expansion Study of FLX475 Monotherapy and in Combination With Pembrolizumab

  NCT03674567· 1/2. fázis· RAPT Therapeutics, Inc., a member of the GSK plc group of companies· Forrás

• Lezárult

  Study of Crenolanib vs Midostaurin Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed FLT3 Mutated AML

  NCT03258931· 3. fázis· Arog Pharmaceuticals, Inc.· Forrás

• Lezárult

  Phase 1-2 Study of Low Dose ASTX727 (ASTX727 LD) in Lower Risk MDS

  NCT03502668· 1/2. fázis· Taiho Oncology, Inc.· Forrás

• Lezárult

  APX005M With Nivolumab and Cabiralizumab in Advanced Melanoma, Non-small Cell Lung Cancer or Renal Cell Carcinoma

  NCT03502330· 1. fázis· Yale University· Forrás

• Lezárult

  Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer

  NCT03511664· 3. fázis· Endocyte· Forrás

• Lezárult

  A Study of Cirmtuzumab and Ibrutinib in Patients With B-Cell Lymphoid Malignancies

  NCT03088878· 1/2. fázis· Oncternal Therapeutics, Inc· Forrás

• Lezárult

  Pembrolizumab Plus Epacadostat, Pembrolizumab Monotherapy, and the EXTREME Regimen in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-669/ECHO-304)

  NCT03358472· 3. fázis· Incyte Corporation· Forrás

• Leállították

  A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer

  NCT03288545· 1/2. fázis· Astellas Pharma Global Development, Inc.· Forrás

• Lezárult

  Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)

  NCT03221426· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  Gain-framed Messages and NRT for Lung Cancer Screening Patients

  NCT03069924· 2. fázis· Medical University of South Carolina· Forrás

• Lezárult

  Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer

  NCT03072238· 3. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  Pembrolizumab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-IIIB Non-Small Cell Lung Cancer

  NCT02621398· 1. fázis· Rutgers, The State University of New Jersey· Forrás

• Lezárult

  Study of Lifileucel (LN-144), Autologous Tumor Infiltrating Lymphocytes, in the Treatment of Patients With Metastatic Melanoma

  NCT02360579· 2. fázis· Iovance Biotherapeutics, Inc.· Forrás

• Leállították

  Novel Combinations of CC-122, CC-223, CC-292, and Rituximab in Diffuse Large B-cell Lymphoma and Follicular Lymphoma

  NCT02031419· 1. fázis· Celgene· Forrás

• Lezárult

  S1001 PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma

  NCT01359592· 2. fázis· SWOG Cancer Research Network· Forrás

• Lezárult

  Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer

  NCT00309985· 3. fázis· ECOG-ACRIN Cancer Research Group· Forrás

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Vesedaganat42 munka · 6 vizsgálat
• Áttétes emlőrák40 munka · 13 vizsgálat
• Tripla negatív emlőrák29 munka · 13 vizsgálat
• Akut mieloid leukémia (AML)23 munka · 8 vizsgálat
• Mielodiszplasztikus szindróma (MDS)20 munka · 5 vizsgálat
• Diffúz nagy B-sejtes limfóma (DLBCL)11 munka · 4 vizsgálat